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The presence of the bacterial genera Corynebacterium and Dolosigranulum has consistently been associated with a healthy upper respiratory tract (URT). Commonly occurring together in the nasopharynx of healthy children, the role of these commensal organisms in nasopharyngeal health is unknown, as few studies have sought to determine whether they actively contribute to maintaining a healthy state. We recently identified Corynebacterium pseudodiphtheriticum and Dolosigranulum pigrum as the major nasopharyngeal species associated with resistance to recurrent ear infections, via 16S rRNA gene sequencing and metagenomics. Using in vitro bacterial interference assays, we observed a reduction in the growth of Moraxella catarrhalisone of the three major otopathogensin the presence of C. pseudodiphtheriticum. Further in vitro and in vivo studies of the interactions between commensal C. pseudodiphtheriticum and D. pigrum strains, URT pathogens, and the human host will help to clarify their role in In Focus nasopharyngeal health. If they play a protective role, these organisms are promising candidates for the development of a probiotic therapy for the treatment or prevention of URT diseases in children.
Human microbiome research has traditionally focused on differences in the composition of the microbial community between healthy and disease states. This research has naturally progressed into 'mining the microbiota for therapeutics'; the process of identifying members of the microbiota that contribute to health and developing them into therapeutic agents, either in the form of probiotics (live, beneficial microorganisms) or isolated antimicrobial compounds. Several examples mirroring this process have already been demonstrated, where defined bacterial mixtures have successfully treated 1 or prevented 2 infection, or the production of an antimicrobial substance by a commensal organism inhibits a pathogenic close relative 3, 4 .
Markers of a healthy nasopharynx
In the microbiome of the upper respiratory tract (URT), the genera Corynebacterium and Dolosigranulum have been consistently associated with health, particularly in children (Table 1 ). In these studies, they are frequently reported to co-occur, their presence corresponds with breastfeeding and a lower risk of respiratory infection, and they appear to be negatively impacted by antibiotic use. This suggests that these genera are important characteristics of a healthy nasopharynx. It may be hypothesised that the absence or reduction (by antibiotic use) of Corynebacterium and Dolosigranulum from the URT microbiota results in respiratory pathogens preferentially colonising the nasopharynx and an increased susceptibility to respiratory disease.
While it is clear that Corynebacterium and Dolosigranulum are strongly associated with health, little work has been done in vitro to characterise how they contribute to health. Do they compete with respiratory pathogens for nutrients and space, or prevent infection via bacterial antagonism? No previous studies appear to have directly tested D. pigrum for such activity. Of those that have investigated Corynebacterium, one early study reported C. pseudodiphtheriticum binding to pharyngeal cells, competitively excluding M. catarrhalis; though no zone of inhibition was observed on blood agar 18 . A more recent study reported that inoculating C. pseudodiphtheriticum strain 090104 into mice improved resistance to infection by respiratory syncytial virus and secondary pneumococcal infection, where non-viable 090104 had a weaker effect 19 . Recently, the commensal also demonstrated inhibition of S. aureus by exploiting its own virulence components 20 .
Other Corynebacterium species have shown similar promising antimicrobial activity; C. propinquum uses siderophores to restrict the availability of iron to coagulase-negative staphylococci 21 , and C. accolens inhibits S. pneumoniae via antimicrobial free fatty acids, which C. accolens requires for growth 10 To attempt to identify the production of an antimicrobial compound by C. pseudodiphtheriticum as a potential mechanism, we inoculated filter paper discs with cell-free C. pseudodiphtheriticum broth culture and cell lysates for a disc diffusion assay on M. catarrhalis. No inhibition was observed ( Figure 2) 22 . It is possible that the inhibitory effect of C. pseudodiphtheriticum is not mediated by an antimicrobial substance, for example by competitive acquisition of nutrients. However, it is also likely that such a substance is produced, but was not successfully extracted from C. pseudodiphtheriticum culture in a functional state or at sufficient concentrations to produce a zone of inhibition, or its production requires a trigger (like the presence of M. catarrhalis). This preliminary work demonstrates that C. pseudodiphtheriticum inhibits the growth of M. catarrhalis; while this is the least common of the major otopathogens, it may be an important one to target In Focus given its apparent synergistic interactions with NTHi and S. pneumoniae 23, 24 . However, the mechanism of interference, the role of D. pigrum and whether Corynebacterium species can inhibit URT pathogens at a clinically useful degree is yet unknown. it has been hypothesised that the production of lactic acid by Table 1 . Studies observing the presence of Corynebacterium and Dolosigranulum in the URT microbiota and their association with a healthy state.
Towards a potential probiotic therapy using

Reference
Major Corynebacterium and Dolosigranulum findings Subjects Table 1) . Previous clinical trials using nasal spray probiotics for children with rAOM have suggested that pre-treatment with antibiotics allows re-establishment of the healthy microbiota, preventing the re-emergence of pathogens 28, 29 .
To fully investigate the possibility that these commensal organisms work synergistically to provide resistance to respiratory pathogens, and the potential for this to be translated into a therapy, there is an array of possibilities for future research. First, it remains likely that C. pseudodiphtheriticum produces an antimicrobial substance that inhibits M. catarrhalis. To isolate it, a range of commensal nasopharyngeal strains could be screened for optimal antimicrobial Further research into the potential of Corynebacterium and Dolosigranulum to compete with respiratory pathogens, alone or in synergy, will provide a strong direction for the use of animal models and clinical trials in the development of a probiotic therapy, which has the potential to treat or prevent a range of upper respiratory illnesses in children.
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